Tocilizumab and Ocrelizumab-related reactions in patients with rare diseases – an analysis of spontaneous reports using the EudraVigilance database

Background: In recent years, several advanced disease-modifying drugs (DMDs) have been approved for the treatment of rare autoimmune disorders. However, data on the safety and effectiveness of these novel DMDs outside the pivotal trials is limited. Hence, the CONTRIBUTE project aims to assess the effectiveness [for full text, please go to the a.m. URL]

Institutions

Publication Details

Journal
German Medical Science (German Research Foundation)
Published
2025-11-11
DOI
https://doi.org/10.3205/25gaa08
Primary Topic
Biosimilars and Bioanalytical Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tocilizumab and Ocrelizumab-related reactions in patients with rare diseases – an analysis of spontaneous reports using the EudraVigilance database

German Medical Science (German Research Foundation)
Biosimilars and Bioanalytical Methods
article

Tocilizumab and Ocrelizumab-related reactions in patients with rare diseases – an analysis of spontaneous reports using the EudraVigilance database

article en

Abstract

Background: In recent years, several advanced disease-modifying drugs (DMDs) have been approved for the treatment of rare autoimmune disorders. However, data on the safety and effectiveness of these novel DMDs outside the pivotal trials is limited. Hence, the CONTRIBUTE project aims to assess the effectiveness [for full text, please go to the a.m. URL]

German Medical Science (German Research Foundation)
Witten/Herdecke University (DE), LMU Klinikum (DE), Rheumazentrum Ruhrgebiet (DE), St. Josef-Hospital (DE), Ludwig-Maximilians-Universität München (DE), Ruhr University Bochum (DE)
Good health and well-being
Openalex Percentile: Top 41%
Biosimilars and Bioanalytical Methods
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Tocilizumab and Ocrelizumab-related reactions in patients with rare diseases – an analysis of spontaneous reports using the EudraVigilance database · German Medical Science (German Research Foundation) (2025) | TGRS Research Map | TGRS